What's coming

Where Sentio is heading.

Sentio starts as a confidential navigator your people can talk to. Here is what we are building around it, with the same data governance and clinical care from the start.

On the way

A few of the things we are building next. Each one extends the same idea: confidential support that meets people where they are.

Knowledge

A deeper knowledge surface.

Beyond conversation, a browsable library of guidance where every answer is sourced, so people can read around a subject in their own time.

For the individual

A private space of your own.

A confidential place to note how you are doing over time. Stored in the UK, visible only to you, never to your employer.

For managers and HR

Support for the people around someone.

Practical templates, conversation guides and adjustment support, so managers and HR can help, without ever seeing anything personal about an individual.

Content

More ways to take it in.

Audio and video alongside the written word, for the moments when reading is not what someone needs.

The next brand

Vivian supports women's health and menopause today. Daniel, our navigator for men's mental health, is built on the same foundations: the same governance, the same clinical care, a voice of its own.

How we build it

A roadmap on a mental-health platform is a promise. These are the rules that keep ours honest.

Clinical review comes first.

Nothing reaches people until it has been through clinical review. That gate is deliberate, and it sets the pace rather than the other way around.

Signal, not surveillance.

Employers see cohort-level signal, never an identifiable individual. Confidentiality is the default, not a setting.

Your data stays in the UK.

Employee data is stored in the UK, and the person always knows what is theirs alone.

Want to help shape what comes next?

We are talking to employers who want to get this right for their people. If that is you, we would like to hear from you.

This page describes our direction, not a fixed timeline. Plans evolve as we learn, and features ship only after clinical review.